Abrilumab (anti-Integrin a4b7 (ITGA4&ITGB7)) is a fully human monoclonal antibody directed against α4β7. Abrilumab (anti-Integrin a4b7 (ITGA4&ITGB7)) selectively binds the α4β7 integrin heterodimer. Abrilumab (anti-Integrin a4b7 (ITGA4&ITGB7)) can be used for the research of inflammatory bowel disease (IBD).
Specification: Low Endotoxin, Azide Free, Validated, Carrier Free, Recombinant, ExactAb™, ≥95%(SDS-PAGE&SEC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB182732-SCI_1cfc4422c020ada8126fd3886edce742.pdf
- UPC:
- 51171829
- Condition:
- New
- Availability:
- 5-10 days
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab182732-100μg
- CAS:
- 1342290-43-0
- Product Size:
- 100μg